A kind of cyclobenzaprine hydrochloride sublingual tablet and preparation method thereof

A technology of cyclobenzaprine hydrochloride and sublingual tablets, which is applied in the direction of pharmaceutical formulas, medical preparations containing no active ingredients, medical preparations containing active ingredients, etc., to achieve stable quality, enhanced drug experience, and remarkable effects

Active Publication Date: 2021-02-26
CP PHARMA QINGDAO CO LTD
View PDF2 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0007] Cyclobenzaprine hydrochloride was first developed by Merk Company. In 1978, cyclobenzaprine hydrochloride tablets were launched in the United States, with specifications of 5mg and 10mg. They are used to relieve muscle spasms accompanied by acute painful musculoskeletal diseases. It is still the most popular drug in the United States. One of the commonly used muscle relaxants, which has not been marketed in China

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • A kind of cyclobenzaprine hydrochloride sublingual tablet and preparation method thereof
  • A kind of cyclobenzaprine hydrochloride sublingual tablet and preparation method thereof
  • A kind of cyclobenzaprine hydrochloride sublingual tablet and preparation method thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0025] Weigh each component according to the following ratio: cyclobenzaprine hydrochloride 20%, sucrose-lactose-mannitol 40% with a weight ratio of 3:2:5, microcrystalline cellulose 15%, carboxymethylcellulose calcium C 10%, 3% sodium saccharin, an appropriate amount of orange flavor, an appropriate amount of sorbic acid, and an appropriate amount of distilled water. Weigh the diluent in proportion, mix it evenly, and pass through an 80-mesh sieve; mix the prepared diluent with cyclobenzaprine hydrochloride, disintegrating agent, corrective agent, essence and preservative, add distilled water to granulate, Lubricant is added and compressed into tablets.

Embodiment 2

[0027] Cyclobenzaprine Hydrochloride 25%, Sucrose-Lactose-Mannitol 3:2:5 by weight 40%, Microcrystalline Cellulose 10%, Carmellose Calcium C 10%, Sodium Saccharin 3%, Orange Flavor Appropriate amount, appropriate amount of sorbic acid, appropriate amount of distilled water. Weigh the diluent in proportion, mix it evenly, and pass through an 80-mesh sieve; mix the prepared diluent with cyclobenzaprine hydrochloride, disintegrating agent, corrective agent, essence and preservative, add distilled water to granulate, Lubricant is added and compressed into tablets.

Embodiment 3

[0029] Cyclobenzaprine hydrochloride 30%, sucrose-lactose-mannitol 45% with a weight ratio of 3:2:5, microcrystalline cellulose 10%, carmellose calcium C 12%, sodium saccharin 1%, orange flavor Appropriate amount, appropriate amount of sorbic acid, appropriate amount of distilled water. Weigh the diluent in proportion, mix it evenly, and pass through an 80-mesh sieve; mix the prepared diluent with cyclobenzaprine hydrochloride, disintegrating agent, corrective agent, essence and preservative, add distilled water to granulate, Lubricant is added and compressed into tablets.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention relates to a cyclobenzaprine hydrochloride sublingual tablet and a preparation method thereof, belonging to the field of pharmaceutical preparations. Cyclobenzaprine hydrochloride sublingual tablet of the present invention preferably comprises cyclobenzaprine hydrochloride 25%, diluent 40%, disintegrant 20%, correctives 3%, and the present invention adopts special weight ratio and is 3:2: 5 of sucrose, lactose and mannitol as diluents, and microcrystalline cellulose 10‑20% and carboxymethylcellulose calcium C 10‑20% as disintegrants, the disintegration of sublingual tablets thus prepared can meet the time limit Requirements, the novel form of sublingual tablet is adopted, and it is disintegrated in the oral cavity when taking it, and combined with the preferred mint essence, it can enhance the consumer's medication experience, with stable quality and remarkable effect.

Description

technical field [0001] The invention relates to the field of pharmaceutical preparations, in particular to a cyclobenzaprine hydrochloride sublingual tablet and a preparation method thereof. Background technique [0002] In a modern society where the pace of life is getting faster and faster, back pain is one of the common diseases. People generally treat it with rest. However, rest cannot solve the fundamental problem. Not being able to work will not only cost a lot of medical expenses, but also long-term and a large number of missed work will affect the gross social product. [0003] Acute pain refers to back and lower back pain that lasts less than 3 months. The initial feeling is muscle spasm, muscle soreness, and limited local activities. The symptoms generally last for several weeks and affect the quality of daily life and work efficiency. If not treated properly , will gradually transform into chronic pain, and further worsen, the situation will become more serious. ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Patents(China)
IPC IPC(8): A61K9/20A61K31/135A61K47/26A61K47/38A61K47/46A61P21/02A61P29/00
CPCA61K9/006A61K9/2018A61K9/2054A61K9/2068A61K31/135
Inventor 王明刚陈阳生刘晓霞孙桂玉臧云龙
Owner CP PHARMA QINGDAO CO LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap